Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Proton Chemotherapy (PCT) for Resectable Esophageal or Esophagogastric Junction Cancer

NCT01684904 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT01684904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01684904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Proton Chemotherapy (PCT) for Resectable Esophageal or Esophagogastric Junction Cancer
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Recruiting
Start date
February 20, 2013
Completion date
August 31, 2032
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus cancer